Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2017 | 1 |
2018 | 1 |
2021 | 1 |
2024 | 0 |
Search Results
2 results
Results by year
Filters applied: . Clear all
Page 1
The EPISOD study: long-term outcomes.
Gastrointest Endosc. 2018 Jan;87(1):205-210. doi: 10.1016/j.gie.2017.04.015. Epub 2017 Apr 25.
Gastrointest Endosc. 2018.
PMID: 28455162
Progesterone Treatment Does Not Decrease Serum Levels of Biomarkers of Glial and Neuronal Cell Injury in Moderate and Severe Traumatic Brain Injury Subjects: A Secondary Analysis of the Progesterone for Traumatic Brain Injury, Experimental Clinical Treatment (ProTECT) III Trial.
Korley F, Pauls Q, Yeatts SD, Jones CMC, Corbett-Valade E, Silbergleit R, Frankel M, Barsan W, Cahill ND, Bazarian JJ, Wright DW.
Korley F, et al. Among authors: pauls q.
J Neurotrauma. 2021 Jul 15;38(14):1953-1960. doi: 10.1089/neu.2020.7072. Epub 2021 Jan 25.
J Neurotrauma. 2021.
PMID: 33319651
Free PMC article.
Clinical Trial.
When examined as a continuous variable, baseline biomarker levels did not modify the association between progesterone treatment and neurological outcome (p of interaction term >0.39 for all biomarkers). We conclude that progesterone treatment does not decrease levels of …
When examined as a continuous variable, baseline biomarker levels did not modify the association between progesterone treatment and neurolog …
Item in Clipboard
Cite
Cite